Patents Assigned to 2cureX
  • Patent number: 10371695
    Abstract: The present invention relates to a method and tools for extracting information on a compounds influence on a cellular phenotype. The method of the invention may be used as a very efficient procedure for testing the efficacy or resistance of single drugs or combinations of drugs on cells from individual patients. Thus, the methods may be useful for predicting efficacy of a drug on a given patient. The methods are also useful for testing of compounds for toxicity, identifying drug targets for known or novel compounds.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: August 6, 2019
    Assignee: 2cureX ApS
    Inventors: Grith Hagel, Ole Thastrup
  • Publication number: 20170131263
    Abstract: The present invention relates to a method and tools for extracting information on a compounds influence on a cellular phenotype. The method of the invention may be used as a very efficient procedure for testing the efficacy or resistance of single drugs or combinations of drugs on cells from individual patients. Thus, the methods may be useful for predicting efficacy of a drug on a given patient. The methods are also useful for testing of compounds for toxicity, identifying drug targets for known or novel compounds.
    Type: Application
    Filed: July 1, 2015
    Publication date: May 11, 2017
    Applicant: 2cureX ApS
    Inventors: Grith Hagel, Ole Thastrup
  • Patent number: 9150899
    Abstract: The present invention relates to methods for identifying compounds capable of modulating a cellular response. The methods involve attaching living cells to solid supports comprising a library of test compounds. The test compounds are linked to the solid support via cleavable linkers and may thus be released from the solid supports. Solid supports comprising cells, wherein the cellular response of interest has been modulated are selected and the test compound of the solid support can then be identified. The cellular response may for example be changes in complex formation between proteins.
    Type: Grant
    Filed: April 6, 2012
    Date of Patent: October 6, 2015
    Assignee: 2cureX
    Inventors: Ole Thastrup, Morten Meldal, Grith Hagel, Jens Chr. Norrild, Morten Hentzer
  • Publication number: 20130123140
    Abstract: The present invention relates to methods for identifying compounds capable of modulating a cellular response. The methods involve attaching living cells to solid supports comprising a library of test compounds. The test compounds are linked to the solid support via cleavable linkers and may thus be released from the solid supports. Solid supports comprising cells, wherein the cellular response of interest has been modulated are selected and the test compound of the solid support can then be identified. The cellular response may for example be changes in complex formation between proteins.
    Type: Application
    Filed: April 6, 2012
    Publication date: May 16, 2013
    Applicant: 2cureX
    Inventors: Ole Thastrup, Morten Meldal, Grith Hagel, Jens Chr. Norrild, Morten Hentzer
  • Patent number: 8318717
    Abstract: The present invention relates to compounds capable of inhibiting binding of the Smac protein to Inhibitors of apoptosis (IAPs). Such compounds are preferably capable of inhibiting IAP and thus may promote apoptosis or sensitize cells for apoptosis. The compounds may be used in the treatment of proliferative diseases, such as cancer.
    Type: Grant
    Filed: May 23, 2006
    Date of Patent: November 27, 2012
    Assignee: 2cureX
    Inventors: Ole Thastrup, Jens Chr. Norrild
  • Publication number: 20090239755
    Abstract: The present invention relates to methods for identifying compounds capable of modulating a cellular response. The methods involve attaching living cells to solid supports comprising a library of test compounds. The test compounds are linked to the solid support via cleavable linkers and may thus be released from the solid supports. Solid supports comprising cells, wherein the cellular response of interest has been modulated are selected and the test compound of the solid support can then be identified. The cellular response may for example be changes in complex formation between proteins.
    Type: Application
    Filed: May 25, 2005
    Publication date: September 24, 2009
    Applicant: 2cureX
    Inventors: Ole Thastrup, Morten Meldal, Grith Hagel, Jens Chr. Norrild, Morten Hentzer